Brief: Immunovant - QTRLY Loss Per Share $0.45
Nov 9 (Reuters) - Immunovant Inc IMVT.O :
* IMMUNOVANT REPORTS FINANCIAL RESULTS AND PROVIDES
CORPORATE
UPDATES FOR THE QUARTER ENDED SEPTEMBER 30, 2023
* IMMUNOVANT INC - QTRLY LOSS PER SHARE $0.45
Source text for Eikon: ID:nGNX6p7szL
Further company coverage: IMVT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Immunovant
See all newsU.S. STOCKS ON THE MOVE-Tesla, Blue Owl, Ford
Immunovant falls as drug for thyroid eye disease fails late-stage trials
Immunovant falls as eye disease therapy fails in late-stage studies
Immunovant Q3 net loss smaller than expected
Brief: Immunovant Q3 Net Income USD -110.635 Million Vs. IBES Estimate USD -125.1 Million